Merck acquired San Diego’s Calporta for up to $576 million
On Nov. 12, 2019, Calporta Therapeutics, one of eight San Diego biotech companies Avalon Ventures created with GlaxoSmithKline, was sold to Merck for up to $576 million.
Tags:
Source: San Diego Union-Tribune
Credit:
